Filing Details

Accession Number:
0001181431-14-027721
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-30 16:03:14
Reporting Period:
2014-07-28
Filing Date:
2014-07-30
Accepted Time:
2014-07-30 16:03:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1138639 Infinera Corp INFN Telephone & Telegraph Apparatus (3661) 770560433
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1399122 F David Welch C/O Infinera Corporation
140 Caspian Court
Sunnyvale CA 94089
President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-07-28 2,500 $9.08 334,479 No 4 S Indirect See Footnote
Common Stock Disposition 2014-07-28 5,000 $9.09 495,000 No 4 S Indirect See Footnote
Common Stock Disposition 2014-07-29 10,000 $9.00 679,493 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 553,750 Indirect See Footnote
Common Stock 2,500 Indirect See Footnote
Common Stock 14,132 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Employee Stock Option (Right to Buy) $2.00 2016-08-08 50,000 50,000 Direct
Common Stock Employee Stock Option (Right to Buy) $2.00 2016-08-08 137,500 137,500 Direct
Common Stock Employee Stock Option (Right to Buy) $8.19 2016-11-23 75,000 75,000 Direct
Common Stock Employee Stock Option (Right to Buy) $7.61 2017-06-06 29,214 29,214 Direct
Common Stock Employee Stock Option (Right to Buy) $7.61 2017-06-06 101,342 101,342 Direct
Common Stock Employee Stock Option (Right to Buy) $7.61 2018-02-28 2,817 2,817 Direct
Common Stock Employee Stock Option (Right to Buy) $7.61 2018-02-28 81,683 81,683 Direct
Common Stock Employee Stock Option (Right to Buy) $7.11 2019-02-10 100,000 100,000 Direct
Common Stock Employee Stock Option (Right to Buy) $7.45 2019-08-10 150,000 150,000 Direct
Common Stock Employee Stock Option (Right to Buy) $8.58 2021-02-10 20,250 20,250 Direct
Common Stock Employee Stock Option (Right to Buy) $8.58 2021-02-10 60,750 60,750 Direct
Common Stock Employee Stock Option (Right to Buy) $8.58 2021-02-10 39,465 39,465 Direct
Common Stock Employee Stock Option (Right to Buy) $8.58 2021-02-10 41,535 41,535 Direct
Common Stock Restricted Stock Units $0.00 26,333 26,333 Direct
Common Stock Restricted Stock Units $0.00 71,250 71,250 Direct
Common Stock Restricted Stock Units $0.00 40,000 40,000 Direct
Common Stock Restricted Stock Units $0.00 48,000 48,000 Direct
Common Stock Restricted Stock Units $0.00 62,770 62,770 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2016-08-08 50,000 50,000 Direct
2016-08-08 137,500 137,500 Direct
2016-11-23 75,000 75,000 Direct
2017-06-06 29,214 29,214 Direct
2017-06-06 101,342 101,342 Direct
2018-02-28 2,817 2,817 Direct
2018-02-28 81,683 81,683 Direct
2019-02-10 100,000 100,000 Direct
2019-08-10 150,000 150,000 Direct
2021-02-10 20,250 20,250 Direct
2021-02-10 60,750 60,750 Direct
2021-02-10 39,465 39,465 Direct
2021-02-10 41,535 41,535 Direct
26,333 26,333 Direct
71,250 71,250 Direct
40,000 40,000 Direct
48,000 48,000 Direct
62,770 62,770 Direct
Footnotes
  1. Shares held directly by LRFA, LLC of which Dr. Welch is the sole managing member.
  2. Shares held directly by The Welch Family Trust u/a dtd 04/03/1996 ("The Welch Family Trust").
  3. Shares held directly by SEI Private Trust Company, Trustee of the Welch Family Heritage Trust I u/I dated 9/24/01.
  4. Shares held directly by The Welch Group, L.P. of which Dr. Welch is the general partner ("The Welch Group").
  5. Shares held directly by Dr. Welch as a trustee for his minor children. Dr. Welch disclaims beneficial ownership of the shares held in trust for his minor children, and this report shall not be deemed an admission that Dr. Welch is the beneficial owner of the shares held in trust for his minor children for purposes of Section 16 or for any other purpose.
  6. The option is fully vested.
  7. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company").
  8. The RSUs vest in three annual installments beginning on February 5, 2013.
  9. The RSUs fully vest on December 31, 2014.
  10. The RSUs vest in three annual installments beginning on February 5, 2014.
  11. The RSUs vest in four annual installments beginning on August 5, 2014.
  12. The RSUs vest in three annual installments beginning on May 5, 2015.
  13. This sale was made in connection with Dr. Welch's Rule 10b5-1 Trading Plan for The Welch Family Trust, which was adopted on May 29, 2014.
  14. This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $9.02 to $9.18 per share. Upon request by the staff of the Securities and Exchange Commission, the Company or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price.
  15. This sale was made in connection with Dr. Welch's Rule 10b5-1 Trading Plan for The Welch Group, which was adopted on May 29, 2014.
  16. This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $9.02 to $9.15 per share. Upon request by the staff of the Securities and Exchange Commission, the Company or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price.
  17. This sale was made in connection with Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on May 24, 2013.
  18. This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $9 to $9.01 per share. Upon request by the staff of the Securities and Exchange Commission, the Company or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price.